Peter Rahmer, See remarks at Relay Therapeutics, Inc. (RLAY), sold 32,807 shares at $3.68 ($121K) on 2025-07-29, disclosed to the SEC on 2025-07-30.
Open-market sale of $121k RLAY by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.74 | 1,359 | $5K | 4.2% |
| 2 | $3.68 | 15,724 | $58K | 47.9% |
| 3 | $3.68 | 15,724 | $58K | 47.9% |
| Total | $3.68 avg | 32,807 | $121K | 100% |
| Filing → |
| RLAY | SELL | 2026-07-02 | $955K | — | Filing → |
| RLAY | SELL | 2026-04-30 | $11K | — | Filing → |
| RLAY | SELL | 2026-01-29 | $100K | — | Filing → |